Consensus-Based Development and Content Validation of Deliberative Criteria for the Evaluation of Innovative and High-Cost Medicines in Mexico: A Delphi Study

Background The evaluation of innovative and high-cost medicines requires deliberative approaches that integrate clinical, economic, ethical, and contextual considerations beyond conventional health technology assessment. This study aimed to develop deliberative criteria and establish their content validity through expert consensus to support the evaluation of these medicines in Mexico. Methods A modified Delphi study was conducted in four phases: development of preliminary criteria by an expert working group, pilot testing, a two-round Delphi process, and framework consolidation. Thirty-three multidisciplinary experts from healthcare institutions, academia, civil society, and the pharmaceutical industry participated. Consensus was predefined as ≥70% agreement; criteria not reaching consensus were revised using qualitative feedback and reevaluated in a second round. Results Pilot testing expanded the 12 preliminary criteria to 14. In Round 1, 12 of 14 criteria reached consensus (agreement 75.8–90.9%). Target population size and definition and Applicability to the national context (69.7% each) were revised; in Round 2 ( n = 30), both reached 100% agreement. The final framework integrates clinical benefit, safety, unmet medical need, evidence quality, implementation feasibility, ethical and equity considerations, real-world evidence, and economic impact. Conclusion A consensus-based framework of 14 content-validated criteria was developed to support transparent and multidimensional evaluation of innovative and high-cost medicines in Mexico, complementing rather than replacing expert judgment.

Authors

Institutions

Publication Details

Journal
Archives of Medical Research
Published
2026-11-21
DOI
https://doi.org/10.1016/j.arcmed.2026.103557
Primary Topic
Delphi Technique in Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Consensus-Based Development and Content Validation of Deliberative Criteria for the Evaluation of Innovative and High-Cost Medicines in Mexico: A Delphi Study

Patricia Clark, David Kershenobich, Carlos A. Hinojosa, Griselda-Adriana Cruz-Priego et al.
Archives of Medical Research
Delphi Technique in Research
article

Consensus-Based Development and Content Validation of Deliberative Criteria for the Evaluation of Innovative and High-Cost Medicines in Mexico: A Delphi Study

Patricia Clark, David Kershenobich, Carlos A. Hinojosa, Griselda-Adriana Cruz-Priego, Xana Esmeralda Robles Cacho, Pamela Stephany Guiovanna Del Moral Villavicencio, Arlene Orta Guerrero, Francisco Hernández Flores, Mariana Beatriz Pineda López
article en

Abstract

Background The evaluation of innovative and high-cost medicines requires deliberative approaches that integrate clinical, economic, ethical, and contextual considerations beyond conventional health technology assessment. This study aimed to develop deliberative criteria and establish their content validity through expert consensus to support the evaluation of these medicines in Mexico. Methods A modified Delphi study was conducted in four phases: development of preliminary criteria by an expert working group, pilot testing, a two-round Delphi process, and framework consolidation. Thirty-three multidisciplinary experts from healthcare institutions, academia, civil society, and the pharmaceutical industry participated. Consensus was predefined as ≥70% agreement; criteria not reaching consensus were revised using qualitative feedback and reevaluated in a second round. Results Pilot testing expanded the 12 preliminary criteria to 14. In Round 1, 12 of 14 criteria reached consensus (agreement 75.8–90.9%). Target population size and definition and Applicability to the national context (69.7% each) were revised; in Round 2 ( n = 30), both reached 100% agreement. The final framework integrates clinical benefit, safety, unmet medical need, evidence quality, implementation feasibility, ethical and equity considerations, real-world evidence, and economic impact. Conclusion A consensus-based framework of 14 content-validated criteria was developed to support transparent and multidimensional evaluation of innovative and high-cost medicines in Mexico, complementing rather than replacing expert judgment.

Archives of Medical ResearchVol. 57(8)
Secretaria de Salud (MX), Secretaria de Salud (HN), Direccion General de Epidemiologia (MX), Universidad Nacional Autónoma de México (MX)
Delphi Technique in Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon